Marken establishs a cGMP cold-chain center in Korea
By Nho, Byung Chul | translator Alice Kang
21.08.09 12:05:00
가나다라
0
Marken and its parent company UPS’s cold-chain distribution center for pharmaceuticals will be complete by October
The 1,000 pyeong sized center will offer freezing, refrigerating, cryogenic preservation systems… has liquid nitrogen (LN2) repositories
Expected to act as an import and export hub for vaccines, biologics, cell and gene therapies in Korea and abroad
▲Image of Marken’s cold-chain logistics center that will be established near the Incheon Airport in October this year
A cGMP compliant cold-chain center for the distribution of pharmaceuticals that will soon be complete in Korea is receiving attention.According to industry sources, the global biopharmaceutical·clinical trial logistics company Marken and its parent company UPS have worked together to establish a 1,000-pyeong cold chain storage and distribution center in Korea. The center will be completed in October.
The importance of the cold-chain system has emerged in the process of distributing COVID-19 mRNA vaccines. Marken’s establishment of the new distribution center near the Incheon Airport is expected to contribute to the establishment of an upgraded biopharmaceutical distribution standard
Nho, Byung Chul(sasiman@dailypharm.com)
If you want to see the full article, please JOIN US (click)